US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
アメリカ
NYSE
AdvanSix Inc (ASIX)
AdvanSix Inc (ASIX) ニュース

AdvanSix Inc (ASIX)

22.16

-0.49

(-2.16%)

終了 6月4日 5:00AM

22.16

0.00

(0.00%)

取引時間後: 8:59AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

AdvanSix Announces First Quarter 2026 Financial Results

1Q26 Sales of $404 million, up 7% versus prior year 1Q26 Earnings Per Share of ($0.58); Adjusted Earnings Per Share of ($0.50) 1Q26 Cash Flow...

AdvanSix Announces Process Design and License Agreement to Assess Expansion of Its Ammonia Platform to Supply Growing Regional Diesel Exhaust Fluid Market

AdvanSix (NYSE: ASIX), a vertically integrated chemistry company serving diverse end markets, today announced it has entered into a process...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 8

AdvanSix (NYSE: ASIX), an integrated chemistry company serving diverse end markets, will issue its first quarter 2026 financial results before...

AdvanSix Appoints Patrick C. Day as Senior Vice President and Chief Financial Officer

AdvanSix (NYSE: ASIX), an integrated chemistry company serving diverse end markets, today announced the...

Form 8-K - Current report

nowwhat2

nowwhat2 3分前

Boy, that was really sumpthin' huh ?

Biotrader23

Biotrader23 5分前

spoke today with Alex Arzeno of SCR Partners whom Terrie K (or jing ma) hired for IR.. dude seems to have decent background in real estate biz namely REITs but complete nube in biotech/healthcare.. they never served any publicly traded biotechs so cant really blame them, they wouldnt say no to new c

norisknorewards

norisknorewards 6分前

Maybe nwbo displayed (the misunderstood) pfs endpoint first (before the OS result), on purpose, on that Mulholland slide deck on that fateful day.

I think, in my opinion, dilution is the last thing LP is worried about, because maybe, maybe, she actually did foresee how this would play

lakers17

lakers17 6分前

Many reasons. Human nature, lack of money, jealousy of others having more success than they do and many more reasons. Like I always say, trust the process. It's clear what is being developed in the US. Clarity is important but so is getting crypto in the Federal Reserve. That's just the US. 21

Investor082

Investor082 7分前

There were a lot of dreamers like you pre TLD and JAMA expecting $20+ share price in 2022 and had already made plans on spending it. Make sure LP and her financiers don’t take you for a ride while you’re en-route to the beach. That scream could end up being in anguish, LOL! ;)

Gravedigger1

Gravedigger1 7分前

Morality?I’m judging your use of time - entirely your choice and on full display - while you have a claim to incredible experience, insight, knowledge, foresight(!!!), and pity the rest of the investment world.
Newsflash:Some people make money and don’t need to “guard” a stock daily.
T

axelvento

axelvento 9分前

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

KEYNOTE-942
After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.

According to

TexasMarvL

TexasMarvL 9分前

CEO Kimberly Ann.
She definitely has a lot of confidence. I want to hang on just to she if she can deliver.

https://youtu.be/htDcyIyYums?si=7RxZ3lRhGaQu-PQE

chen1992

chen1992 10分前

The fact that we aren’t talking about FID anymore and now all eyes are on the 8-K is surreal. It feel dream like after so many letdowns

douginil

douginil 13分前

Hmmmm

I wonder if our process into metals and oxides gets us into 5 nine purity.

Investor2014

Investor2014 14分前

Ah, OhSay’s older and wiser brother finally arrives, very late in the Anavex saga and, unlike his younger brother, having actually made money from his $AVXL insights. That apparently now qualifies you to lecture others on morality and judge message-board posters with unwavering conviction.

Investors3

Investors3 14分前

I agree with you. If BTC was a good investment at a higher price, then why not buy more, when it is down? I actually find my crypto investments much more exciting than my stock investments. And being able to buy when i want (24 x7) is also a nice benefit. Yes, i don't understand why some people cele

georgejjl

georgejjl 15分前

New Treatment for Alzheimer’s and Parkinson’s Discovered in JapanResearchers use a vitamin K and vitamin A hybrid to transform stem cells into functional neurons, offering a potential path to restoring lost brain function.

https://www.inc.com/lucia-auerbach/future-of-brain-health-how-

ZenChimera371

ZenChimera371 15分前

So, a couple things here.

1. There seems to be inconsistency in the filing regarding communication about convertible debt reduction. They claimed 1 million reduction but I am not seeing that reduction noted in the actual filings for that time period.

2. How are they avo

Biotrader23

Biotrader23 16分前

call it BS since they signed off on the CSR

SemperFITrader

SemperFITrader 17分前

FMc, Both CTBVEAG and CHM are under Licensing, how many times do I have to say that, nothing else really has to be stated past that. CTA data is meaningless since it relates to Clinical Trial Acceptance. Marketing Authorisation under Licenses is the key to both meetings period.
I asked you

Split T

Split T 18分前

Wow, LIBOR and Ezell litigation ends and some of you think that the price is dropping because sellers are pulling listings..lol. you might ought to rethink why the shorts are buying hand over fist.

Biotrader23

Biotrader23 21分前

Been holding sig AVXL position for the last 5 years, regulatory setbacks are common in biotech world, some of my best winners had to overcome those..

Since we have no cash/runway issues my biggest worry at the moment is the direction: Jing Ma (aka SPAC queen) firmly in charge, just lo

Nightdaytrader

Nightdaytrader 22分前

There are so many mistakes and falsehoods in this AI Project West post. Too many to comment on..

There is also this AI statement which is totally wrong. AI stated: "Releasing JPM and others from potential claims (including willful misconduct carve-outs or negotiations around them)

GreenShoots

GreenShoots 27分前

Everybody sees what you refuse to. Don’t be mad cuz you down and out. Don’t hate people that have been here for so long and NOW see the TRUTH. You wanna go down with the ship, do it. Just don’t hate people that see what is happening

skitahoe

skitahoe 28分前

I believe it the Will Rodger's simple stock advice, Buy Good Stock.
The fact that it's been down much of the time I've been in it leads to his principle that if it's up, good, if it's down, better, buy more.

If the stock had moved up from the time I first bought it, I doubt i

cadillacdave

cadillacdave 32分前

There is a high short interest here, so there will be a lot of volatility. Sell the spikes and buy the lows.

It's been a traders stock for quite some time. When big news hits and takes out the shorts, things may change here.

lakers17

lakers17 34分前

BTC back over $64,400. Trust the process, ignore the noise. It's pretty simple. Either you believe in crypto and are holding or averaging down and or you don't believe in crypto and never buy anything. Every time BTC drops the noise emerges out of the closet. I have most on ignore now. I will

JusDePomme

JusDePomme 35分前

Look for devs type move here ahead

JusDePomme

JusDePomme 36分前

Can't believe some traders attack bid after hour while PPS look stunning all day with new high

PYC Therapeutics

Simplify Us Equity Plus ...

WisdomTree Multi Asset I...

Bahl and Gaynor Small Mi...

Fiducial Office Solutions

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。